Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as noted in the metadata request) on March 29, 2011. The report discloses the issuance of a press release regarding consolidated financial results for the third quarter of fiscal year 2011, which ended on February 27, 2011.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1), which is incorporated by reference but not reproduced in the body of this 8-K document.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It serves solely as a notification that the third-quarter results have been announced via a press release.
Guidance, Outlook, and Risks
The text contains no management commentary, forward-looking guidance, risk factors, or discussion of unusual items. The document explicitly states that the information is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net income, EPS) by reviewing Exhibit 99.1 (the Press Release dated March 29, 2011), as they are absent from this summary text.
- Confirm the registrant is Landec Corporation, noting the discrepancy with the "Lifecore Biomedical, Inc." name in the request metadata.
- Check the fiscal quarter end date of February 27, 2011 to ensure correct period comparison.